Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-based optimizations of a necroptosis inhibitor (SZM594) as novel protective agents of acute lung injury
Lijuan Xu, Ye Tu, Jiao Li, et al.
Chinese Chemical Letters (2021) Vol. 33, Iss. 5, pp. 2545-2549
Closed Access | Times Cited: 23

Showing 23 citing articles:

Acute lung injury: a view from the perspective of necroptosis
Jinyan Dong, Weihong Liu, Wenli Liu, et al.
Inflammation Research (2024) Vol. 73, Iss. 6, pp. 997-1018
Closed Access | Times Cited: 6
Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors
Shenghua Gao, Letian Song, Tobias Claff, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16902-16917
Closed Access | Times Cited: 25
Targeting Receptor-Interacting Protein Kinase 1 by Novel Benzothiazole Derivatives: Treatment of Acute Lung Injury through the Necroptosis Pathway
Xinqi Zhang, Qianyu Han, Ruilin Hou, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 5261-5278
Closed Access | Times Cited: 13
Natural Product-Inspired Targeted Protein Degraders: Advances and Perspectives
Jiao Li, Zhenyu Cai, Xu‐Wen Li, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 20, pp. 13533-13560
Closed Access | Times Cited: 21
Crystallography-Guided Optimizations of the Keap1–Nrf2 Inhibitors on the Solvent Exposed Region: From Symmetric to Asymmetric Naphthalenesulfonamides
Guodong Liu, Ruilin Hou, Lijuan Xu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 12, pp. 8289-8302
Closed Access | Times Cited: 20
Targeting Necroptosis as a Promising Therapy for Alzheimer’s Disease
Wenli Zhao, Yue Liu, Lijuan Xu, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 12, pp. 1697-1713
Closed Access | Times Cited: 19
Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease
Yi Sun, Lijuan Xu, Hongming Shao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14957-14969
Closed Access | Times Cited: 17
AB-Gen: Antibody Library Design with Generative Pre-Trained Transformer and Deep Reinforcement Learning
Xiaopeng Xu, Tiantian Xu, Juexiao Zhou, et al.
Genomics Proteomics & Bioinformatics (2023) Vol. 21, Iss. 5, pp. 1043-1053
Open Access | Times Cited: 10
Profiling of small‐molecule necroptosis inhibitors based on the subpockets of kinase–ligand interactions
Lijuan Xu, Chunlin Zhuang
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 1974-2024
Closed Access | Times Cited: 8
Investigation on the chemical space of the substituted triazole thio-benzoxazepinone RIPK1 inhibitors
Yanan Hao, Hongming Shao, Zhuo Qu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 236, pp. 114345-114345
Closed Access | Times Cited: 13
Structure-Based Design of Novel Alkynyl Thio-Benzoxazepinone Receptor-Interacting Protein Kinase-1 Inhibitors: Extending the Chemical Space from the Allosteric to ATP Binding Pockets
Danni Quan, Ruilin Hou, Hongming Shao, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 3073-3087
Closed Access | Times Cited: 6
Role of Necroptosis in Central Nervous System Diseases
Hongming Shao, Wenbin Wu, Pei Wang, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 23, pp. 3213-3229
Closed Access | Times Cited: 9
Neuroprotective effect of a Keap1-Nrf2 Protein-Protein Inter-action inhibitor on cerebral Ischemia/Reperfusion injury
Zengxin Qi, Yusheng Tong, Hao Luo, et al.
Bioorganic Chemistry (2023) Vol. 132, pp. 106350-106350
Closed Access | Times Cited: 5
Rational Optimizations of the Marine‐Derived Peptide Sungsanpin as Novel Inhibitors of Cell Invasion
Anpeng Li, Jihua Zou, Xiaobin Zhuo, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 2
Closed Access | Times Cited: 5
Synthesis of challenging 6-functionalized 1-oxaspiro[3.3]heptanes – New scaffolds for drug discovery
Yevhenii Kozyriev, Vitalii A. Palchykov
Tetrahedron Letters (2023) Vol. 122, pp. 154515-154515
Open Access | Times Cited: 5
Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity
Jingjie Fang, Houzong Yao, Chunlin Zhuang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15288-15308
Closed Access | Times Cited: 5
Rational drug design of CB2 receptor ligands: from 2012 to 2021
Yan-Ran Wu, Jia-qin Tang, Wannian Zhang, et al.
RSC Advances (2022) Vol. 12, Iss. 54, pp. 35242-35259
Open Access | Times Cited: 8
Discovery of novel biaryl benzoxazepinones as dual-mode receptor-interacting protein kinase-1 (RIPK1) inhibitors
Y.‐C. XIN, Pengcheng Dai, Hongming Shao, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 100, pp. 117611-117611
Closed Access | Times Cited: 1
Profiling of the chemical space on the phenyl group of substituted benzothiazole RIPK3 inhibitors
Yue Xu, Caiquan Liang, Wannian Zhang, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106339-106339
Closed Access | Times Cited: 7
Analysis on benzothiazole necroptosis inhibitors with chiral substitutions in the solvent-accessible region of RIP kinase domain
Hongming Shao, Lijuan Xu, Gechang Li, et al.
Bioorganic Chemistry (2023) Vol. 137, pp. 106647-106647
Closed Access | Times Cited: 2
Discovery of Natural Products to SARS-CoV-2 with Comparative Molecular Docking and Moderate Cell Proliferation Inhibition in vitro
Shiwei Yang, Xinming Hu, Jinmiao Zhu, et al.
(2024)
Open Access
Discovery of a Novel Benzimidazole Necroptosis Inhibitor from an In-House Compound Library
Yu Zou, Chai Yue, Hongming Shao, et al.
Pharmaceutical Fronts (2024) Vol. 06, Iss. 03, pp. e283-e293
Open Access
AB-Gen: Antibody Library Design with Generative Pre-trained Transformer and Deep Reinforcement Learning
Xiaopeng Xu, Tiantian Xu, Juexiao Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top